Systematic comparison of somatic variant calling performance among different sequencing depth and mutation frequency

[1]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[2]  Birgit Funke,et al.  Best practices for benchmarking germline small-variant calls in human genomes , 2019, Nature Biotechnology.

[3]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[4]  A. Halpern,et al.  Strelka2: fast and accurate calling of germline and somatic variants , 2018, Nature Methods.

[5]  Christopher T. Saunders,et al.  Strelka2: fast and accurate calling of germline and somatic variants , 2018, Nature Methods.

[6]  Jia Gu,et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.

[7]  M. Tarnopolsky,et al.  Whole‐exome sequencing is a valuable diagnostic tool for inherited peripheral neuropathies: Outcomes from a cohort of 50 families , 2018, Clinical genetics.

[8]  C. Marshall,et al.  Prospective cohort study for identification of underlying genetic causes in neonatal encephalopathy using whole-exome sequencing , 2017, Genetics in Medicine.

[9]  S. Eschrich,et al.  Evaluating somatic tumor mutation detection without matched normal samples , 2017, Human Genomics.

[10]  Joel Pel,et al.  Duplex Proximity Sequencing (Pro-Seq): A method to improve DNA sequencing accuracy without the cost of molecular barcoding redundancy , 2017, bioRxiv.

[11]  V. Marx.  How to deduplicate PCR , 2017, Nature Methods.

[12]  J. Rosenfeld,et al.  Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals , 2017, Circulation. Arrhythmia and electrophysiology.

[13]  Jefferey Chen,et al.  Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels , 2017, PloS one.

[14]  Andrew C. Adey,et al.  Sequencing thousands of single-cell genomes with combinatorial indexing , 2017, Nature Methods.

[15]  Walter J Curran,et al.  Lung cancer: current therapies and new targeted treatments , 2017, The Lancet.

[16]  M. Weerts,et al.  Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases , 2016, Molecular oncology.

[17]  Lin He,et al.  In-depth comparison of somatic point mutation callers based on different tumor next-generation sequencing depth data , 2016, Scientific Reports.

[18]  Mariella G. Filbin,et al.  Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma , 2016, Nature.

[19]  M. Berger,et al.  Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Xiaoyu Chen,et al.  Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications , 2016, Bioinform..

[21]  Lincoln D. Stein,et al.  Simple, multiplexed, PCR-based barcoding of DNA enables sensitive mutation detection in liquid biopsies using sequencing , 2016, Nucleic acids research.

[22]  Mads Thomassen,et al.  Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data , 2016, PloS one.

[23]  Ash A. Alizadeh,et al.  Integrated digital error suppression for improved detection of circulating tumor DNA , 2016, Nature Biotechnology.

[24]  Wendy K Chung,et al.  Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing , 2015, Genetics in Medicine.

[25]  O. Hofmann,et al.  VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research , 2016, Nucleic acids research.

[26]  Michael C. Heinold,et al.  A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing , 2015, Nature Communications.

[27]  Geoffrey R. Oxnard,et al.  Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients , 2015, Clinical Cancer Research.

[28]  S. Mundlos,et al.  Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein‐Coding Regions , 2015, Human mutation.

[29]  Michael Boutros,et al.  Amplicon Sequencing of Colorectal Cancer: Variant Calling in Frozen and Formalin-Fixed Samples , 2015, PloS one.

[30]  M. Tétreault,et al.  Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities , 2015, Expert review of molecular diagnostics.

[31]  Theresa Zhang,et al.  Personalized genomic analyses for cancer mutation discovery and interpretation , 2015, Science Translational Medicine.

[32]  A. Iafrate,et al.  Anchored multiplex PCR for targeted next-generation sequencing , 2014, Nature Medicine.

[33]  Mikhail Shugay,et al.  Towards error-free profiling of immune repertoires , 2014, Nature Methods.

[34]  K. Robasky,et al.  The role of replicates for error mitigation in next-generation sequencing , 2013, Nature Reviews Genetics.

[35]  Marilyn M. Li,et al.  Clinical application of amplicon-based next-generation sequencing in cancer. , 2013, Cancer genetics.

[36]  Peilin Jia,et al.  Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers , 2013, Genome Medicine.

[37]  Mauricio O. Carneiro,et al.  From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.

[38]  Jay Shendure,et al.  Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation , 2013, Genome research.

[39]  Jesse J. Salk,et al.  Detection of ultra-rare mutations by next-generation sequencing , 2012, Proceedings of the National Academy of Sciences.

[40]  H. Swerdlow,et al.  A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers , 2012, BMC Genomics.

[41]  T. Dallman,et al.  Performance comparison of benchtop high-throughput sequencing platforms , 2012, Nature Biotechnology.

[42]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[43]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[44]  S. Linnarsson,et al.  Counting absolute numbers of molecules using unique molecular identifiers , 2011, Nature Methods.

[45]  Heng Li,et al.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data , 2011, Bioinform..

[46]  K. Kinzler,et al.  Detection and quantification of rare mutations with massively parallel sequencing , 2011, Proceedings of the National Academy of Sciences.

[47]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[48]  K. Flaherty,et al.  Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.

[49]  A. Tutt,et al.  Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial , 2010, The Lancet.

[50]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[51]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[52]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[53]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[54]  R. Hansen,et al.  Molecular barcodes detect redundancy and contamination in hairpin-bisulfite PCR. , 2004, Nucleic acids research.

[55]  H. Hug,et al.  Measurement of the number of molecules of a single mRNA species in a complex mRNA preparation. , 2003, Journal of theoretical biology.

[56]  D. Bentley.  Current Challenges and Future Opportunities , 1989, Infection Control & Hospital Epidemiology.